<DOC>
	<DOCNO>NCT01710826</DOCNO>
	<brief_summary>To assess healthy adult subject : - The tolerability safety ascend repeated oral dos Genz-682452 . - The pharmacokinetic parameter Genz-682452 ascend repeat oral dos . - The pharmacodynamics Genz-682452 ascend repeat oral dos .</brief_summary>
	<brief_title>A Safety , Tolerability , Pharmacokinetics , Pharmacodynamics Study Genz-682452 Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Body weight 50.0 95.0 kg , inclusive , male 40.0 85.0 kg inclusive , female , body mass index 18.0 30.0 kg/m^2 , inclusive . Certified healthy comprehensive clinical assessment . Any history presence clinically relevant cardiovascular , pulmonary , gastrointestinal , hepatic , renal , metabolic , hematological , neurological , osteomuscular , articular , psychiatric , systemic , ocular , gynecologic ( female ) , infectious disease , sign acute illness . Frequent headache and/or migraine , recurrent nausea and/or vomit . Blood donation , volume , within 2 month inclusion . Symptomatic postural hypotension . History presence drug alcohol abuse . Positive result follow test : hepatitis B surface ( HBs Ag ) antigen , antihepatitis C virus ( antiHCV ) antibody , antihuman immunodeficiency virus 1 2 antibody ( antiHIV1 anti HIV2 Ab ) . Positive result urine drug screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>